Hong Kong Respiratory Medicine

Joint Website of HKTS, ACCP HK & Macau, HKLF

  • Increase font size
  • Default font size
  • Decrease font size
The Lancet and the Lancet series of journals
Title Filter     Display # 
# Article Title Hits
1 2012 Feb-4 Optimising therapy for EGFR-addicted NSCLC: just the start 1
2 2012 Jan-8 A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies 18
3 2012 Jan-8 Beyond first-line NSCLC therapy: chemotherapy or erlotinib? 10
4 2012 Jan-8 Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial 32
5 2012 Jan-8 Surgical treatment of drug-resistant tuberculosis 20
6 2012 Jan-22 Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden 14
7 2012 Jan-8 EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implication 63
8 2012 Jan-8 Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives 62
9 2011 Dec-25 Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives 46
10 2011 Dec-25 Tests for prediction of active tuberculosis 72
11 2011 Dec 25 Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis 15
12 2011 Dec-25 Estimating the effect of influenza vaccines 69
13 2011 Dec-25 Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysi 43
14 2011 Dec 12 - β-agonists for ARDS: the dark side of adrenergic stimulation? 105
15 2011 Dec-17 Effect of intravenous β-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial 76
16 2011 Dec-10 Tracheobronchial transplantation with a stem-cell-seeded bioartificial nanocomposite: a proof-of-concept study 128
17 2011 Dec-4 Serotype replacement in disease after pneumococcal vaccination 101
18 2011 Dec-4 DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials 81
19 2011 Nov-26 Autoimmune diseases and risk of pulmonary embolism 124
20 2011 Nov-26 Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden 86
21 2011 Nov-11 Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial 91
22 2011 Nov-6 EGFR expression as a predictor of survival for first-line chemotherapy plus cetuximab in patients with advanced non-small-cell lung cancer: analysis of data from the phase 3 FLEX study 121
23 2011 Oct-30 The global rise of extensively drug-resistant tuberculosis: is the time to bring back sanatoria now overdue? 99
24 2011 Oct-30 Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis 122
25 2011 Oct-22 Therapeutic vaccination with TG4010 and first-line chemotherapy in advanced non-small-cell lung cancer: a controlled phase 2B trial 120
26 2011 Oct-22 Point-of-care tuberculosis diagnosis: are we there yet? 189
27 2011 Oct-22 Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study 67
28 2011 Sep-25 Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis 150
29 2011 Sep-10 Controversies in treatment of chronic obstructive pulmonary disease 196
30 2011 Sep-10 The future of chronic obstructive pulmonary disease treatment—difficulties of and barriers to drug development 233
31 2011 Sep-10 New insights into the immunology of chronic obstructive pulmonary disease 158
32 2011 Sep-10 Bronchoscopic lung-volume reduction with Exhale airway stents for emphysema (EASE trial): randomised, sham-controlled, multicentre trial 147
33 2011 Sep-10 Lifetime risk of developing chronic obstructive pulmonary disease: a longitudinal population study 148
34 2011 Sep-10 Management of asthma in pregnancy guided by measurement of fraction of exhaled nitric oxide: a double-blind, randomised controlled trial 210
35 2011 Aug-20 Efficacy and safety of tigecycline for the treatment of infectious diseases: a meta-analysis 157
36 2011 Aug-20 Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis 167
37 2011 Aug-20 Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis 162
38 2011 Aug-14 Carboplatin and weekly paclitaxel doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer: IFCT-0501 randomised, phase 3 trial 200
39 2011 July-31 Prevention of ventilator-associated pneumonia with oral antiseptics: a systematic review and meta-analysis 214
40 2011 July-31 Palaeogenomics of Mycobacterium tuberculosis: epidemic bursts with a degrading genome 181
41 2011 July-31 Fact and fiction in tuberculosis vaccine research: 10 years later 241
42 2011 July-23 EGFR exon 20 insertion mutations in non-small-cell lung cancer: preclinical data and clinical implications 261
43 2011 July- 23 Molecular biomarkers in non-small-cell lung cancer: a retrospective analysis of data from the phase 3 FLEX study 233
44 July 2011 July- 23 Erlotinib, gefitinib, or chemotherapy for EGFR mutation-positive lung cancer? 406
45 2011 July-23 Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study 203
46 2011 July-2 Surgery for mesothelioma? The debate continues 267
47 2011 July-2 Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study 101
48 2011 July-2 Idiopathic pulmonary fibrosis 288
49 2011 July-2 Text messaging in smoking cessation: the txt2stop trial 239
50 2011 July-2 Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial 134
51 2011 June 25- The European Respiratory Roadmap 176
52 201 June 25- Outpatient management of pulmonary embolism 320
53 2011 June 25- Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial 317
54 2011 June 25- Tuberculosis 174
55 2011 June 25- Non-small-cell lung cancer 215
56 2011 June 25- Small-cell lung cancer 119
57 2011 June-19 Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study 154
58 2011 June-19 Chloroquine for influenza prevention: a randomised, double-blind, placebo controlled trial 196
59 2011 June-19 Palaeogenomics of Mycobacterium tuberculosis: epidemic bursts with a degrading genome 220
60 2011 June-12 Glucocorticoid treatment in community-acquired pneumonia 298
61 2011 June-12 Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial 161
62 2011 May 29- Tuberculosis and cancer: a complex and dangerous liaison 352
63 2011 May 29- Screening of immigrants in the UK for imported latent tuberculosis: a multicentre cohort study and cost-effectiveness analysis 184
64 2011 May 29- Salvage with erlotinib plus bevacizumab: not in NSCLC 295
65 2011 May 29- Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial 201
66 2011 May 15 - Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials 364
67 2011 May 7- 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial 148
68 2011 May 2- Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study 243
69 2011 Apr 13 - Lancet Comment: Isoniazid preventive therapy in HIV infection 370
70 2011 Mar 23 - Viral pneumonia 260
71 2011 Mar 16 - Prevalence of Heavy Smoking in California and the United States, 1965-2007 231
72 2011 Mar 18 - Tuberculosis 247
73 2011 Feb 16 - Lancet Comment: Cell-culture-derived influenza vaccine production 524
74 2011 Feb 16 - Efficacy, safety, and immunogenicity of a Vero-cell-culture-derived trivalent influenza vaccine: a multicentre, double-blind, randomised, placebo-controlled trial 246
75 2011 Feb 15 - Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial 364
76 2011 Feb 15 Lancet Comment: New insights into the treatment of persistent asthma 473
77 2011 Jan - Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study 395
78 2011 Jan 6 - Lancet Comment: Vitamin D nutrient to treat TB begs the prevention question 690
79 2011 Jan 6 - High-dose vitamin D3 during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial 506
80 2011 Jan - First-cycle rash and survival in patients with advanced non-small-cell lung cancer receiving cetuximab in combination with first-line chemotherapy: a subgroup analysis of data from the FLEX phase 3 study 354
81 2010 Dec 17 - Head-to-head comparison of pandemic influenza vaccines 466
82 2010 Dec 17 - Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial 322
83 2010 Dec 17 - Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial 326
84 2010 Nov 23 - Influenza in young children: burden, immunisation, and policy 279
85 2010 Nov 23 - Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study 265
86 2010 Dec 9 - Tuberculosis burden in households of patients with multidrug-resistant and extensively drug-resistant tuberculosis: a retrospective cohort study 399
87 2010 Nov 26 - Second-hand smoke's worldwide disease toll 439
88 2010 Nov 26 - Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries 431
89 2010 Nov 2 - Priorities for tuberculosis research: a systematic review 338
90 2010 Nov 1 - Aerosol drug delivery: developments in device design and clinical use 375
91 2010 Oct 14 - Genetics of lung-cancer susceptibility 375
92 2010 Oct 12 - New driver mutations in non-small-cell lung cancer 422
93 2010 Oct - Tuberculosis case-contact research in endemic tropical settings: design, conduct, and relevance to other infectious diseases 339
94 2010 Oct 4 - Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial 322
95 2010 Oct 4 - Lancet Comment: Active case-finding for TB in the community: time to act 482
96 2010 Sep 1 - Scale-up of diagnostics for multidrug resistant tuberculosis 481
97 2010 Sep 1 - Microscopic-observation drug susceptibility and thin layer agar assays for the detection of drug resistant tuberculosis: a systematic review and meta-analysis 423
98 2010 Sep 4 - The role of dendritic and epithelial cells as master regulators of allergic airway inflammation 455
99 2010 Sep 4 - Role of viral respiratory infections in asthma and asthma exacerbations 391
100 2010 Sep 4 - Management of severe asthma in children 475
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
Page 1 of 2

Administrators' Area (Requires Login)

Who's Online

We have 11 guests online

Statistics since July 2009

Content View Hits : 535098